Fig. 2

The phenotype of NK cells after the culturing of PBMCs from healthy subjects with seronegative plasma (Neg), anti-D1(+) plasma (D+), and anti-D1(−) plasma (D−). a the percentage and MFI of activation marker CD69 on NK cells in all studied groups; b representative dot-plots of NK cell (CD3−/CD16+/CD56+) distribution in three studied groups showing CD16/CD56^bright phenotype of NK cells in seronegative and anti-D1(−) groups and CD16/CD56^dim phenotype of NK cells in anti-D1(+) group